In the final week of the Musk v. Altman trial, lawyers traded blows over Elon Musk’s and OpenAI CEO Sam Altman’s credibility. Altman was grilled on his alleged history of lying and self-dealing involving companies that do business with OpenAI. But he fired back, painting Musk as a power-seeker who wanted to control the development…
The retail trading subreddit submitted the sharpest criticism yet in response to the financial regulator’s idea of letting companies report twice per year.
U.S. House lawmakers want to know how hackers broke into education tech giant Instructure twice, and stole reams of data from students who use the company’s flagship student data software Canvas.
From October 13-15, TechCrunch Disrupt 2026 will feature 200+ sessions across six stages, led by 250+ tech leaders shaping the industry today. Register now to save up to $410, plus 50% off a second pass.
Poppy is an AI-powered app that connects your calendar, email, messages, and other services to surface reminders, suggestions, and tasks based on what’s happening in your life.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. A plan to make drugs in orbit is going commercial A startup called Varda Space Industries is betting that the future of pharmaceuticals lies in orbit. The company has signed a…
Adaption’s new AutoScientist tool is designed to let models adapt to specific capabilities quickly through an automated approach to conventional fine-tuning.
Varda Space Industries, a startup that’s been pitching its ability to perform drug experiments in space, says it has signed up the pharmaceutical company United Therapeutics in what may be remembered as a notable step toward in-orbit manufacturing. The idea of building things in outer space for use on Earth has so far been explored…
From sales tax compliance to entity structure and year-end planning, these common tax mistakes can quietly drain profits and create costly problems for growing businesses.